Welcome to the 11th IMPACCT RWE Summit
After returning for its 11th year, the IMPACCT: Real World Evidence Summit 2023 deep dived into the use of RWE for regulatory submissions and clinical trial innovation to unlock unstructured healthcare data and transform disease treatment.
Following exciting FDA and EMA changes, this comprehensive industry-led forum addressed how drug developers can leverage RWE from the beginning to the end of a study, ensuring clinical studies are well-designed, include appropriate protections for their patients and upload data integrity.
100+ senior leaders in RWE, RWD, real world analytics experts & epidemiologists from pharma and biotech came together to take part in this three-day summit with over 18 hours of exclusive content.
Your peers learnt how to leverage the new FDA external controls draft guidance to create synthetic control arms using RWE, as well as EHR data and artificial intelligence. This unique opportunity allowed attendees to explore how to leverage RWE to target patient populations and drive DE&I into trials.
What You Missed:
Harness the full potential of RWE:
Explore how to leverage RWE from the beginning to the end of a study, ensuring clinical studies are well-designed, include appropriate protections for their patients and upload data integrity
Join 100+ senior leaders
Unite with RWE, RWD, real world analytics experts & epidemiologists from pharma and biotech to connect over three-days and a staggering 18 hours of exclusive, game-changing content!
Mastering FDA Guidance
Learn how to leverage the new
FDA external controls
draft guidance to create synthetic
control arms using RWE,
as well as EHR data
and artificial intelligence.
The 2023 Expert Speaker Faculty Included:
Alexander Cole
Executive Director, Head of Epidemiology & Real World Science
Alexion Pharmaceuticals
Charles Makin
Global Head Of Value & Access, Pipeline Franchise, Health Economics & Outcomes Research
Biogen